# C_2015095EN.01002001.xml

| 21.3.2015 | EN | Official Journal of the European Union | C 95/20 |
| --------- | -- | -------------------------------------- | ------- |

---

COMMISSION DECISION

of 20 March 2015

appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency

(2015/C 95/09)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency( 1 ), and in particular Article 65(3) thereof,

Whereas:

| (1) | In 2010, Commission Decision of 14 December 2010 appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency( 2 ) appointed two Commission representatives and two alternates to the Management Board of the European Medicine Agency (hereinafter ‘the Agency’). |
| --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |

| (2) | Due to changes in the organisation chart of the Commission, it is necessary to adopt a new decision, replacing Commission Decision of 14 December 2010 and appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency, |
| --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |

HAS DECIDED AS FOLLOWS:

Article 1

The representatives of the Commission to the Management Board of the European Medicines Agency shall be the persons occupying the following positions and exercising the following functions:

| (1) | from the Directorate-General for Health and Food Safety:
(a)
as member, the Director-General of the Directorate-General for Health and Food Safety; (b)
as alternate, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Health and Food Safety; | (a) | as member, the Director-General of the Directorate-General for Health and Food Safety; | (b) | as alternate, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Health and Food Safety; |
| --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --- | -------------------------------------------------------------------------------------- | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| (a) | as member, the Director-General of the Directorate-General for Health and Food Safety; | | | | |
| (b) | as alternate, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Health and Food Safety; | | | | |

| (2) | from the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs:
(a)
as member, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs; (b)
as alternate, the Head of Unit heading the Unit which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs. | (a) | as member, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs; | (b) | as alternate, the Head of Unit heading the Unit which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs. |
| --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| (a) | as member, the Director heading the Directorate which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs; | | | | |
| (b) | as alternate, the Head of Unit heading the Unit which is responsible for medicinal products, within the remit of responsibilities assigned to the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs. | | | | |

Article 2

This Decision shall apply to the persons occupying, including on a temporary basis, the positions referred to in Article 1 at the date of adoption of this Decision, or to any successor of those persons in those positions.

Article 3

The Director-Generals of the Directorate-General for Health and Food Safety and the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs shall inform the Chair of the Management Board and the Executive Director of the Agency of the names of the persons occupying the positions referred to in Article 1, and any changes thereof.

Article 4

Commission Decision of 14 December 2010 appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency is repealed.

This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 20 March 2015. For the Commission Vytenis ANDRIUKAITIS Member of the Commission

---

( 1 )  OJ L 136, 30.4.2004, p. 1.

( 2 )  OJ C 340, 15.12.2010, p. 17.

---